SCHEMBL723385

SCHEMBL723385

Cn1cc(-c2ccc(-c3cc4nccc(-c5ccc(N)nc5)c4o3)cc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.43
KIT P10721 1/20 0.43
LRRK2 Q5S007 1/20 0.42
MAP4K4 O95819 1/20 0.41
MET P08581 2/20 0.40
CCNC P24863 4/20 0.38
CDK8 P49336 4/20 0.38
AURKB Q96GD4 3/20 0.38
MAP3K7 O43318 1/20 0.38
KDR P35968 1/20 0.38
TAB1 Q15750 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
ALK Q9UM73 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PI4KA P42356 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722106 0.93 MTOR (0.47) MTORKITLRRK2MAP4K4MET
SCHEMBL15209645 0.88 CCNC (0.39) LRRK2MAP4K4METCCNCCDK8
SCHEMBL724193 0.85 MET (0.46) KITMAP4K4METPIK3CAFEN1
SCHEMBL15209552 0.85 FGFR1 (0.41) METCCNCCDK8PIK3CDPIK3CA
SCHEMBL721690 0.85 AURKB (0.38) LRRK2MAP4K4METCCNCCDK8
SCHEMBL723758 0.85 DYRK1A (0.47) LRRK2CCNCCDK8AURKBMAP3K7
SCHEMBL722505 0.84 CCNC (0.42) LRRK2METCCNCCDK8AURKB
SCHEMBL722999 0.84 CCNC (0.43) LRRK2CCNCCDK8PIM1PIM2
SCHEMBL10268949 0.84 AURKB (0.46) MTORLRRK2MAP4K4METCCNC
SCHEMBL722397 0.83 AURKB (0.44) MTORLRRK2MAP4K4METAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB MTOR 2383/4885KIT 1865/4885LRRK2 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.